Table 1.

Demographic Characteristics, Health Status, and Psychiatric Treatment Use (n = 1,340)

Demographics and Psychiatric Treatment Use	Depression/anxiety + ASD (n = 268)	Depression/anxiety only (n = 1,072)
Sex
Male	68.7%	68.7%
Female	31.3%	31.3%
Race/Ethnicity
African-American	7.9%	7.9%
Hispanic	4.1%	4.1%
White	84.3%	84.3%
Other	3.7%	3.7%
Mean age	26.20	26.20
18–29 years	76.1%	76.1%
30–39 years	13.1%	13.1%
40–49 years	6.7%	6.7%
50–65 years	4.1%	4.1%
Chronic illness 6 month pre-depression/anxiety diagnosis	4.1%	2.3%
Chronic illness during 2009	11.9%	12.6%
Other comorbid psychiatric disorder
ADHD***	10.4%	3.3%
Bipolar	14.9%	12.9%
Substance abuse***	4.1%	21.9%
Schizophrenia	5.6%	4.2%
Intellectual disability***	8.2%	.6%
Other psychiatric disorder**	28.0%	20.1%
Psychotropic medication use among full sample
Antidepressant	51.1%	51.6%
Antipsychotic***	39.6%	21.5%
Benzodiazepine	28.0%	24.2%
CNS stimulant***	11.9%	6.1%
Monthly mean number of psychotropic medication use days among users
Antidepressant***	24.18	16.91
Antipsychotic***	25.04	15.35
Benzodiazepine***	20.78	14.67
CNS stimulant*	23.22	18.74
Talk therapy use
Individual talk therapy	73.5%	72.1%
Individual talk therapy for anxiety/depression*	57.1%	64.3%
Group therapy*	0.7%	2.9%
Case management***	27.2%	7.7%
Monthly mean number of talk therapy use among users
Individual talk therapy***	.64	.44
Individual talk therapy for anxiety/depression	.35	.37
Group therapy	.10	.28
Case management*	.61	.41
Two or more psychotropic medication use**	47.0%	36.3%
Three or more psychotropic medication use*	20.9%	15.2%

Note.

^*p<.05,

^**p<.01,

^***p<.001.

Values in bold font indicate the significantly higher group.